Li, L., Li, J., Ren, J., & Yao, J. (2025). Isorhamnetin Exhibits Hypoglycemic Activity and Targets PI3K/AKT and COX-2 Pathways in Type 1 Diabetes. Nutrients, 17(20), 3201. https://doi.org/10.3390/nu17203201
Citace podle Chicago (17th ed.)Li, Lijia, Jia Li, Jie Ren, a Jengyuan Yao. "Isorhamnetin Exhibits Hypoglycemic Activity and Targets PI3K/AKT and COX-2 Pathways in Type 1 Diabetes." Nutrients 17, no. 20 (2025): 3201. https://doi.org/10.3390/nu17203201.
Citace podle MLA (9th ed.)Li, Lijia, et al. "Isorhamnetin Exhibits Hypoglycemic Activity and Targets PI3K/AKT and COX-2 Pathways in Type 1 Diabetes." Nutrients, vol. 17, no. 20, 2025, p. 3201, https://doi.org/10.3390/nu17203201.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..